Silvia Ríos‐Romenets

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

Joseph F. Arboleda‐Velásquez, Francisco Lopera, Michael O’Hare et al. · Nature Medicine · 2019 · 559 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Genetics +8

Validation of the MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma, Werner Poewe, Irene Litvan et al. · Movement Disorders · 2018 · 287 citations

Movement disorder society criteria for clinically established early Parkinson's disease

Daniela Berg, Charles H. Adler, Bastiaan R. Bloem et al. · Movement Disorders · 2018 · 169 citations · Full text

Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study

Yakeel T. Quiroz, Henrik Zetterberg, Eric M. Reiman et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Longitudinal Cohort Study, Neurodegenerative Diseases, Molecular Neuroscience +10

The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort

Pierre N. Tariot, Francisco Lopera, Jessica B. Langbaum et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 129 citations · Full text